Skip to content
Finbold Logo

To keep going please Log in.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Sign up.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Sign up.

Sign Up Sign In
or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

LABD Direxion Daily S&P Biotech Bear 3X Shares
$7.44 2.89% +0.21
Add to watchlist Add alerts
Notify me if price changes either direction
1% 5% 10% 15%
Loading

ETF statistics

Avg 10 volume 13.4M
Avg 90 volume 11.2M

ETF price summary

Fifty two week low 4.78
Fifty two week high 16.05
Fifty two week change 1.545
Day 50 ma 8.4452
Day 200 ma 7.2748

Dividends and splits

Forward annual dividend rate 0.10926
Forward annual dividend yield 0.014675620883917
Trailing annual dividend rate 0.11237
Trailing annual dividend yield 0.015093350894433
Dividend frequency Semi-Annual
Ex dividend date 2025-03-25
Last split factor 1-for-20 split
Last split date 2020-08-28

Recent LABD News

Trade, Swap & Stake Crypto on Uphold

Buy, sell, and swap crypto. Stake crypto, earn rewards and securely manage 300+ assets—all in one trusted platform. Terms apply. Capital at risk.

Get Started

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.